{
    "2021-06-28": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Is This Chinese Biopharma Stock Still a Buy?",
                "features": {
                    "keywords": [
                        "Chinese",
                        "Biopharma",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval",
                "features": {
                    "keywords": [
                        "High-Dividend",
                        "Stocks",
                        "Cathie Wood",
                        "Approval"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks",
                        "growth"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis appoints Rob Kowalski as Chief People & Organization Officer",
                "features": {
                    "keywords": [
                        "Novartis",
                        "appoints",
                        "Rob Kowalski",
                        "Chief People & Organization Officer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "management"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}